Yumanity Therapeutics Inc

NASDAQ:YMTX   3:59:51 PM EDT
3.75
-0.08 (-2.09%)
Earnings Announcements

Yumanity Therapeutics Reports Q3 Loss Per Share $0.97

Published: 11/15/2021 12:57 GMT
Yumanity Therapeutics Inc (YMTX) - Yumanity Therapeutics Reports Third Quarter 2021 Financial Results and Recent Corporate Developments.
Q3 Loss per Share $0.97.
Revenue is expected to be $1.81 Million
Adjusted EPS is expected to be -$1.05

Next Quarter Revenue Guidance is expected to be $1.5 Million
Next Quarter EPS Guidance is expected to be -$1.09

More details on our Analysts Page.